TrialThe Journal of infectious diseases2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
Selin Somersan-Karakaya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it